ATE439852T1 - Verwendung eines centella asiatica extraktes , der reich an madecassoside und terminoloside ist - Google Patents

Verwendung eines centella asiatica extraktes , der reich an madecassoside und terminoloside ist

Info

Publication number
ATE439852T1
ATE439852T1 AT03815106T AT03815106T ATE439852T1 AT E439852 T1 ATE439852 T1 AT E439852T1 AT 03815106 T AT03815106 T AT 03815106T AT 03815106 T AT03815106 T AT 03815106T AT E439852 T1 ATE439852 T1 AT E439852T1
Authority
AT
Austria
Prior art keywords
terminoloside
madecassoside
extract
passing
mixture
Prior art date
Application number
AT03815106T
Other languages
English (en)
Inventor
Alain Loiseau
Gerard Sene
Eric Theron
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Application granted granted Critical
Publication of ATE439852T1 publication Critical patent/ATE439852T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
AT03815106T 2002-12-10 2003-12-10 Verwendung eines centella asiatica extraktes , der reich an madecassoside und terminoloside ist ATE439852T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0215613A FR2848117B1 (fr) 2002-12-10 2002-12-10 Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
PCT/FR2003/003651 WO2004062678A1 (fr) 2002-12-10 2003-12-10 Procede de preparation d’un extrait de centella asiatica riche en madecassoside et en terminoloside

Publications (1)

Publication Number Publication Date
ATE439852T1 true ATE439852T1 (de) 2009-09-15

Family

ID=32320170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03815106T ATE439852T1 (de) 2002-12-10 2003-12-10 Verwendung eines centella asiatica extraktes , der reich an madecassoside und terminoloside ist

Country Status (12)

Country Link
US (3) US7402669B2 (de)
EP (1) EP1569672B1 (de)
JP (1) JP4643275B2 (de)
KR (2) KR20110132629A (de)
CN (1) CN1774257A (de)
AT (1) ATE439852T1 (de)
AU (1) AU2003296799A1 (de)
CA (1) CA2509421C (de)
DE (1) DE60328912D1 (de)
ES (1) ES2329568T3 (de)
FR (1) FR2848117B1 (de)
WO (1) WO2004062678A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012015A2 (en) * 2004-06-29 2006-02-02 Oregon Health And Science University Methods and compositions for nerve regeneration
FR2888114B1 (fr) * 2005-07-07 2009-10-30 Oreal Utilisation cosmetique du madecassoside et/ou du terminoloside comme agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
WO2007054211A1 (en) * 2005-11-09 2007-05-18 Bayer Consumer Care Ag Use of compounds from centella asiatica
JP5266254B2 (ja) * 2007-02-12 2013-08-21 インダス バイオテック プライベート リミテッド 選択的セロトニン再取り込み阻害組成物およびその方法
BRPI0700767B8 (pt) 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
FR2914857B1 (fr) * 2007-04-12 2011-01-21 Dermathologiques D Uriage Lab Compositions anti-inflammatoires et leur utilisation en cosmetique et/ou en dermatologie
WO2008142619A1 (en) * 2007-05-17 2008-11-27 Izun Pharmaceuticals Corporation Use of herbal compositions in the protection and enhancement of extracellular matrix components
US8742167B2 (en) * 2008-01-11 2014-06-03 Shanghai Institute Of Pharmaceutical Industry Therapeutic formulations based on asiatic acid and selected salts thereof
FR2929118B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
FR2929117B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
US8071139B2 (en) * 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
FR2932986B1 (fr) * 2008-06-26 2010-12-10 Michele Evrard Composition regeneratrice de la peau
CN101323637B (zh) * 2008-07-29 2010-12-22 卢照凯 一种积雪草甙及其制备方法
CN101407536B (zh) * 2008-11-27 2011-05-18 浙江大学 一种溶剂结晶法制备高纯度积雪草苷的工艺
FR2943253B1 (fr) 2009-03-20 2011-04-22 Oreal Composition contenant l'association de madecassoside, d'une arginine et de polysorbate
DE102009026718A1 (de) 2009-06-04 2010-04-15 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung II
JP2011057634A (ja) * 2009-09-11 2011-03-24 Rohto Pharmaceutical Co Ltd 美白用組成物
WO2011043735A1 (en) * 2009-10-07 2011-04-14 Asian Phytoceuticals Public Company Limited A composition for modulating immune responses
US8685472B2 (en) 2010-03-01 2014-04-01 Access Business Group International Llc Skin whitening composition containing chia seed extract
JP5913297B2 (ja) 2010-06-10 2016-04-27 インダス バイオテック プライベート リミティド センテラ・アジアティカからの高純度アジアチコサイドの製造法及びその使用法
FR2964570A1 (fr) 2010-09-09 2012-03-16 Burgundy Procede de preparation d'un extrait de centella asiatica
WO2012050763A2 (en) 2010-09-29 2012-04-19 Access Business Group International Llc Chia seed extract and related method of manufacture
CN102603854A (zh) * 2011-01-25 2012-07-25 苏州宝泽堂医药科技有限公司 一种从积雪草中提取积雪草皂苷的方法
KR101245563B1 (ko) * 2011-03-16 2013-03-21 바이오스펙트럼 주식회사 마데카소사이드를 함유하는 피부 미백제
JP5926506B2 (ja) * 2011-06-23 2016-05-25 バイオランド・リミテッド コラーゲン産生促進剤の製造方法、ｍｍｐ−１阻害剤の製造方法及び皮膚外用組成物の製造方法
DE102011083293A1 (de) 2011-09-23 2013-03-28 Henkel Ag & Co. Kgaa Wasserfreie Formulierungen mit kühlender Wirkung
CN102367263B (zh) * 2011-11-11 2013-05-29 上海师范大学 一种分离纯化积雪草三萜酸单葡萄糖苷的方法
CN103796631A (zh) * 2012-06-29 2014-05-14 生物光谱公司 含有羟基积雪草苷的皮肤美白组合物
FR3005575B1 (fr) * 2013-05-20 2016-01-01 Oreal Composition cosmetique comprenant un agent antipelliculaire, un bisabolol et un compose de type madecassoside, et procede de traitement cosmetique
CN105168051A (zh) * 2015-09-16 2015-12-23 任海锋 肤色遮盖液
CN105267056A (zh) * 2015-12-01 2016-01-27 江苏隆力奇生物科技股份有限公司 一种具有抗皱祛皱功能的护肤化妆品组合物及其应用
CN107412235A (zh) * 2017-06-28 2017-12-01 上海交通大学 一种积雪草中促进pc12细胞分化的单体组合及其应用
CN107903296B (zh) * 2017-11-29 2021-01-26 桂林融通科技有限公司 羟基积雪草苷的提取方法
WO2020112590A1 (en) 2018-11-27 2020-06-04 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Solubilised centella asiatica extract
CN112773806B (zh) * 2019-11-06 2024-03-19 鲁南制药集团股份有限公司 包含淫羊藿苷元和羟基积雪草酸的药物组合物的医药用途
CN111285916B (zh) * 2020-02-14 2021-07-02 浏阳朗林生物科技有限公司 一种积雪草总苷含量高的积雪草提取物的制备方法
CN112957379B (zh) * 2021-02-20 2022-04-08 上海珈凯生物科技有限公司 一种积雪草提取物的提取方法
WO2023036404A1 (en) 2021-09-07 2023-03-16 Symrise Ag Taste balancing botanical compounds
WO2023123046A1 (en) * 2021-12-29 2023-07-06 L'oreal Composition for caring for the skin
CN115228432B (zh) * 2022-05-31 2023-04-25 西南科技大学 用于放射性核素富集的生物质衍生碳包裹纳米零价铁材料的制备及应用
CN114989239B (zh) * 2022-07-05 2023-04-18 广西昌洲天然药业有限公司 一种从积雪草中分离羟基积雪草苷方法及计算机存储介质
CN116407478A (zh) * 2023-05-11 2023-07-11 杭州以息互联网科技有限公司 一种温和的祛痘组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5975M (de) * 1966-08-08 1968-04-22
KR910002518B1 (ko) * 1989-03-09 1991-04-23 동국제약 주식회사 적설초에서 게닌성분 및 아시아티코사이드의 분리방법
ATE252367T1 (de) 1996-04-23 2003-11-15 Procter & Gamble Verfahren und regelung des hautaussehens mit vitamin - b3 - verbindungen
KR100228873B1 (ko) 1997-03-24 1999-11-01 강재헌 센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제
FR2768927B1 (fr) 1997-10-01 2000-01-21 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
AU7651100A (en) * 1999-09-15 2001-04-17 Roche Consumer Health Ag Pharmaceutical and/or cosmetical compositions
US6416769B1 (en) * 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof

Also Published As

Publication number Publication date
US20120178706A1 (en) 2012-07-12
JP2006516962A (ja) 2006-07-13
US20060106206A1 (en) 2006-05-18
US8486900B2 (en) 2013-07-16
CA2509421A1 (fr) 2004-07-29
JP4643275B2 (ja) 2011-03-02
US7402669B2 (en) 2008-07-22
US8163706B2 (en) 2012-04-24
KR101122786B1 (ko) 2012-04-12
KR20110132629A (ko) 2011-12-08
DE60328912D1 (de) 2009-10-01
AU2003296799A1 (en) 2004-08-10
WO2004062678A1 (fr) 2004-07-29
ES2329568T3 (es) 2009-11-27
EP1569672A1 (de) 2005-09-07
EP1569672B1 (de) 2009-08-19
KR20060069349A (ko) 2006-06-21
CA2509421C (fr) 2012-02-07
FR2848117A1 (fr) 2004-06-11
US20080118581A1 (en) 2008-05-22
FR2848117B1 (fr) 2006-08-04
CN1774257A (zh) 2006-05-17

Similar Documents

Publication Publication Date Title
ATE439852T1 (de) Verwendung eines centella asiatica extraktes , der reich an madecassoside und terminoloside ist
CN105154509A (zh) 一种人参肽的提取方法
CN104592341A (zh) 一种从积雪草中提取积雪草苷、羟基积雪草苷的方法
CN104450190A (zh) 烟用春黄菊浸膏的制备方法
CN105481711A (zh) 一种羟基-β-山椒素单体的制备方法
CN108047110A (zh) 一种以枸杞为原料制备玉米黄素双棕榈酸酯的方法
CN104666430A (zh) 一种响应面法优化提取茉莉总黄酮的方法
CN101007797A (zh) 一种从枳椇子中提取二氢杨梅素的方法
CN102115467A (zh) 一种单体儿茶素的制备方法
CN103610717B (zh) 一种采用超临界co2萃取、有机溶剂提取蜂花粉和刺五加复方提取物的制备及纯化方法
CN103819518A (zh) 杜仲松脂醇二葡萄糖苷标准提取物的制备方法
ATE204758T1 (de) Verfahren zur herstellung von heilpflanzenextrakten
CN103833802A (zh) 一种红景天苷的制备方法
CN102060706A (zh) 一种从紫锥菊中提取纯化菊苣酸的方法
CN203938622U (zh) 一种用于杜仲翅果桃叶珊瑚苷提取的装置
CN104523462B (zh) 化妆品级葛根异黄酮的纳滤膜分离制备方法
CN102648939A (zh) 一种路边青多酚的制备方法
CN106281713A (zh) 一种玫瑰精油的提取方法
CN109423357A (zh) 一种广藿香挥发油的提取方法
RU2007111457A (ru) Применение чабера горного (satureja montana) или его экстрактов при получении лекарственных средств для лечения преждевременной эякуляции
CN106221929A (zh) 从附生兰提取精油的方法
CN116515559B (zh) 一种基于亚临界低温萃取工艺提取沉香精油的方法
CN1330324C (zh) 一种从花锚植物中提取抗肝炎有效成分的方法
MX2012013678A (es) Procedimiento para preparar un extracto enriquecido a partir de hojas de vitis vinifera l.
CN102093749A (zh) 五味子天然色素的制备技术

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties